Protein Expression Changes in Ovarian Cancer during the Transition from Benign to Malignant-Reference-Cited by-同舟云学术

Protein Expression Changes in Ovarian Cancer during the Transition from Benign to Malignant

Published:2012-04-17 Issue:5 Volume:11 Page:2876-2889
ISSN:1535-3893
Container-title:Journal of Proteome Research
language:en
Short-container-title:J. Proteome Res.

Author:

Waldemarson Sofia,Krogh Morten,Alaiya Ayodele¹,Kirik Ufuk,Schedvins Kjell²,Auer Gert³,Hansson Karin M.,Ossola Reto⁴,Aebersold Ruedi⁴⁵,Lee Hookeun⁴,Malmström Johan,James Peter

Affiliation:

1. Proteomics Unit, Stem Cell Therapy Program, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia

2. Gynecological Unit, Karolinska University Hospital, Stockholm, Sweden

3. Karolinska Biomic Center, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden

4. Department of Biology, Institute for Molecular Systems Biology, ETH Zurich (Swiss Federal Institute of Technology), ETH Hönggerberg, Wolfgang-Pauli-Strasse 16, HPT, CH-8093 Zurich, Switzerland

5. Faculty of Science, University of Zurich, Switzerland

Publisher

American Chemical Society (ACS)

Subject

General Chemistry,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/pr201258q

Reference34 articles.

1. Surveillance procedures for patients treated for epithelial ovarian cancer: a review of the literature

2. Progress and Challenges in Screening for Early Detection of Ovarian Cancer

3. Role of p53 and Rb in Ovarian Cancer

4. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigm